A pilot study by Victorian neurologists has shown that Neurofilament Light (NfL) may be a useful biomarker to distinguish primary psychiatric disorders from neurodegenerative and neurological disorders. Researchers at the Royal Melbourne Hospital have shown that cerebrospinal fluid (CSF) levels of NfL are significantly higher in patients with neurological disorders such as early-onset dementia compared ...
Novel biomarker may distinguish neurological and psychiatric disorders
By Michael Woodhead
26 Jun 2019